| Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Reference |
| Bioavailability |
95.0 |
% |
>95 |
% |
|
DRUGBANK |
| Metabolic |
62.5 |
% |
60-65 |
% |
|
DRUGBANK |
Metabolic |
37.5 |
% |
35-40 |
% |
Urinary excretion; |
DRUGBANK |
| Clearance |
10.5 |
L/h |
50-300 |
ml/min |
Hepatitis, Hep; |
DRUGBANK |
Clearance |
0.46 |
L/h/kg |
7.7 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
| Volume of Distribution |
2.0 |
L/kg |
2.0 |
L/kg |
|
DRUGBANK |
Volume of Distribution |
1.2 |
L/kg |
1.2 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
| Half-life |
3.5 |
h |
3-4 |
h |
|
DRUGBANK |
Half-life |
2.2 |
h |
2.2 |
h |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
| Toxicity LD50 |
263.0 |
mg/kg |
263.0 |
mg/kg |
PO, oral; Rattus, Rat; |
DRUGBANK |
| Eliminate Route |
7.5 |
% |
~6-9 |
% |
Faeces excretion; intravenous injection, IV; |
DRUGBANK |
Eliminate Route |
37.5 |
% |
35-40 |
% |
Urinary excretion; human, homo sapiens; Unchanged drug; |
DRUGBANK |
| Protein Binding |
40.0 |
% |
40 |
% |
|
DRUGBANK |